Opportunistic infections such as Candida, Aspergillus, and Cryptococcus are significant contributors to illness and mortality, partic-ularly in those with compromised immune systems. The innate and adaptive immune systems collaborate to ensure host protection. Pattern recognition receptors in innate immunity are the primary line of defense. They identify fungal fragments and emit signals that induce swelling. The immune system must generate cytokines and activate immune cells to eradicate fungi. This is particularly applicable to reactions from Th1 and Th17. Fungal diseases are emerging with numerous strategies to circumvent human defenses, such as altering their morphology, developing biofilms, and concealing characteristics that elicit an immune response. These modi-fications facilitate prolonged infection persistence. The rise of antifungal resistance, caused by genetic mutations, efflux pumps, and biofilm-associated protection, has diminished the efficacy of conventional antifungal medicines. This review delineates the host immune system's response to fungal infections and examines the primary mechanisms of antifungal resistance. It also discusses novel approaches to treatment, such as combination therapy and immunomodulatory techniques, aimed at enhancing the immune system and improving treatment efficacy. To enhance the efficacy and specificity of antifungal therapies, it is imperative to deepen our understanding of the interactions between infections and hosts.
Post-COVID-19 syndrome symptoms include circulatory abnormalities, respiratory problems, mental health concerns, and chronic fatigue. The burden that these illnesses placed on the global healthcare system led to a rise in complementary and alternative medicine, particularly medicinal plant therapies. Medicinal plants have long been used in traditional medicine for their antiviral, immunomodulatory, antioxidant, and anti-inflammatory properties. These properties are currently being studied. By lowering oxidative damage, immune response modulation, and chronic inflammation, these compounds with bioactive properties could assist in lessening the long-term consequences of COVID-19. Additional clinical trials were needed to verify the safety and efficacy of these medicines, even though initial study results suggested that medicinal plants might aid COVID-19 patients in recovering and living longer. The article provides comprehensive medical strategies that consider the needs of patients post COVID-19. It is recommended to use evidence-based medicinal herbs in addition to traditional therapy